Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2500 participants
OBSERVATIONAL
2023-03-15
2023-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chinese Psoriasis Real World Evidence Research
NCT04465838
Study of Psoriatic Arthritis
NCT00001420
The Relationship Between Moderate-to-severe Psoriasis and Sleep Disturbance
NCT06165887
Association Between the Occurrence of a Clinical RElapse and Gut MIcrobiota Modifications: a Cohort Study of Patients With pSOriasis
NCT06055699
Safety and Efficacy of Etanercept in Patients With Psoriasis
NCT02258282
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Psoriasis patients registered in the database;
3. Patients or their families can cooperate to complete the follow-up information survey (questionnaire, telephone, etc.) independently, and ensure the authenticity of the data provided.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gang Wang, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gang Wang, MD
Chief Director of Department of Dermatology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GANG WANG, M.D.
Role: PRINCIPAL_INVESTIGATOR
Xijing Hospital, The Fourth Military Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
The First Hospital of Lanzhou University
Lanzhou, Gansu, China
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China
The Second Hospital of Jilin University
Changchun, Jilin, China
Dalian Dermatosis Hospital
Dalian, Liaoning, China
Xining First People's Hospital
Xining, Qinghai, China
Xijing Hospital, The Fourth Military Medical University
Xi'an, Shaanxi, China
Shanghai Skin Disease Hospital, Tongji University School of Medicine
Shanghai, Shanghai Municipality, China
The University of Hong Kong-Shenzhen Hospital
Shenzhen, Shenzhen, China
West China Hospital, Sichuan University
Chengdu, Sichuan, China
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
Tianjin, Tianjin Municipality, China
People's Hospital of Xinjiang Uygur Autonomous Region，Xinjiang Key Laboratory of Dermatology Research
Ürümqi, Xinjiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
CHEN YU
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
CHEN YU
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Liu Y, Xu Z, Zhou J, Chen A, Zhang J, Kang X, Jiang X, Lyu C, Shi C, Shi Y, Liu X, Li F, Yang B, Huang Y, Yu C, Wang G. Clinical characteristics and outcomes of psoriasis patients with COVID-19: A retrospective, multicenter cohort study in China. Chin Med J (Engl). 2024 Jul 20;137(14):1736-1743. doi: 10.1097/CM9.0000000000003024. Epub 2024 May 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XJPF202303-PSO&COVID-19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.